Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	perineuronal net	HAPLN4 BCAN ACAN	4.44e-05	10	153	3	GO:0072534
GeneOntologyCellularComponent	perisynaptic extracellular matrix	HAPLN4 BCAN ACAN	6.08e-05	11	153	3	GO:0098966
GeneOntologyCellularComponent	synapse-associated extracellular matrix	HAPLN4 BCAN ACAN	1.04e-04	13	153	3	GO:0099535
GeneOntologyCellularComponent	anchoring junction	FLNA FLNB ANK2 SYNM LAMA3 IGSF5 PCDHA12 SYNPO MAST2 PIKFYVE PDPN ARHGAP22 AFAP1 SCN2A TNKS1BP1 GJC3 CGNL1 TNS3	2.90e-04	976	153	18	GO:0070161
GeneOntologyCellularComponent	3M complex	CCDC8 CUL7	5.25e-04	5	153	2	GO:1990393
Domain	Znf_C2H2-like	ZHX3 ZNF627 ZNF444 ZNF609 ZNF219 ZNF628 ZBTB22 ZBTB9 ZBTB47 ZNF318 ZNF236 ZXDB PRDM8 BCL11B KLF1 ZNF335 ZFP64 ZNF646	6.59e-05	796	149	18	IPR015880
Domain	ZnF_C2H2	ZHX3 ZNF627 ZNF444 ZNF609 ZNF219 ZNF628 ZBTB22 ZBTB9 ZBTB47 ZNF318 ZNF236 ZXDB PRDM8 BCL11B KLF1 ZNF335 ZFP64 ZNF646	7.98e-05	808	149	18	SM00355
Domain	ZINC_FINGER_C2H2_2	ZHX3 ZNF627 ZNF444 ZNF609 ZNF219 ZNF628 ZBTB22 ZBTB9 ZBTB47 ZNF236 ZXDB PRDM8 BCL11B KLF1 ZNF335 ZFP64 ZNF646	1.53e-04	775	149	17	PS50157
Domain	ZINC_FINGER_C2H2_1	ZHX3 ZNF627 ZNF444 ZNF609 ZNF219 ZNF628 ZBTB22 ZBTB9 ZBTB47 ZNF236 ZXDB PRDM8 BCL11B KLF1 ZNF335 ZFP64 ZNF646	1.58e-04	777	149	17	PS00028
Pathway	REACTOME_ECM_PROTEOGLYCANS	COL5A2 LAMA3 BCAN ACAN LRP4 TNXB	3.22e-05	76	113	6	M27219
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	UNC13B TRPM4 FLNA TBC1D9B ZNF628 EML2 ATG2A ZNF236 MAST2 HDAC7 PPP1R26 PIKFYVE EHBP1L1 SUGP2 ZNF335 LRP4 TNKS1BP1 HECTD1 RGL2 HCFC1 MED12 WNK2 PRRC2B	7.59e-10	1105	154	23	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF609 ZNF219 ERCC6 ADAMTS1 ZBTB9 MCC RNF213 ZNF318 CUL7 MAST2 DMAP1 BCL11B HMCN2 SUGP2 EHMT2 MEPCE LRP4 MACF1 AGTPBP1 PRRC2B ZNF646	2.54e-08	1116	154	21	31753913
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	CUL3 ZHX3 FLNA GAPVD1 HIRIP3 MINK1 NASP RFFL ZNF318 RFX7 HDAC7 SUGP2 TKT ZNF335 TNKS1BP1 CDK11B AGTPBP1	6.87e-08	774	154	17	15302935
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	UNC13B FLNB ANK2 KIF1A ADAMTS1 SYNM ZBTB47 NASP SYNPO CLIC6 DMAP1 EHMT2 LRP4 MACF1 ANKRD24 EXOC1 DGCR8 RAB11FIP4 HECTD1 GPRASP2 AGTPBP1	2.67e-07	1285	154	21	35914814
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	FLNA FLNB GAPVD1 ZNF609 ZBTB9 POU5F1 ZNF318 PHC1 EHMT2 TNKS1BP1 MED12 GPRASP2	4.00e-07	418	154	12	34709266
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ZHX3 ZNF219 TBX4 KIF1A ZBTB22 ZNF318 RXRB PHC1 RING1 PIKFYVE BCL11B IGHMBP2 ZFP64 MACF1 USF2	6.77e-07	709	154	15	22988430
Pubmed	High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.	RAD51D ZNF609 ZNF219 IMPA2 OGFR NASP EML2 SYNPO RING1 EHBP1L1 DMKN TKT DNAAF10 MEPCE PPIP5K1 TNKS1BP1 CDK11B CGNL1	7.00e-07	1021	154	18	26760575
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TRPM4 FLNB ZNF444 ZNF609 MIA3 IMPA2 KIF1A NPEPPS MINK1 LAMA3 RNF213 SYNPO AHCYL2 ZNF236 SUGP2 ASMTL ZFP64 SETBP1 MACF1 ANKRD24 HECTD1 WNK2	7.39e-07	1489	154	22	28611215
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CUL3 GAPVD1 ZNF609 SYNPO ATG2A FEM1C DMAP1 AFAP1 SETBP1 LRP4 TNKS1BP1 WNK2 ZNF646	7.50e-07	529	154	13	14621295
Pubmed	High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions.	ZBTB22 ZBTB9 POU5F1 RXRB RING1 EHMT2 RGL2 TNXB	1.22e-06	175	154	8	19851445
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	FLNA FLNB GAPVD1 KIF1A NPEPPS ZNF318 CUL7 SUGP2 MACF1 TNKS1BP1 HECTD1 HCFC1 MED12 PRRC2B	1.39e-06	653	154	14	22586326
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CUL3 MIA3 ZNF219 ANK2 NPEPPS MINK1 ZBTB22 MCC SYNPO ZNF318 BCL11B EHMT2 PPP1R3F MACF1 BRSK1 WNK2 PRRC2B	1.43e-06	963	154	17	28671696
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CUL3 FLNA FLNB ANK2 NPEPPS MINK1 SYNPO BCAN AFAP1 SUGP2 TKT CRACDL SCN2A MACF1 TNKS1BP1 EXOC1 CGNL1 BRSK1 WNK2 AGTPBP1 PRRC2B	1.51e-06	1431	154	21	37142655
Pubmed	Molecular cloning of Bral2, a novel brain-specific link protein, and immunohistochemical colocalization with brevican in perineuronal nets.	HAPLN4 BCAN ACAN	1.69e-06	6	154	3	14550776
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	WHRN CUL7 MAST2 PPP1R26 LRP4 MACF1 HECTD1	1.95e-06	130	154	7	12421765
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UNC13B WHRN ZHX3 AHCYL2 SNX19 SUGP2 MACF1 PPIP5K1 RAB11FIP4 AGTPBP1 PRRC2B	2.22e-06	407	154	11	12693553
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	FLNA FLNB ANK2 PCDHA12 PCDHA5 CUL7 EHMT2 SLC24A1 RGL2 WNK2	2.31e-06	329	154	10	17474147
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	COL5A2 ZHX3 GAPVD1 ERCC6 NPEPPS NASP IGHMBP2 MEPCE CDK11B HCFC1 HYDIN MED12	2.43e-06	497	154	12	36774506
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ZHX3 ZNF609 ZBTB9 DMAP1 EHMT2 MEPCE HCFC1 MED12 PRRC2B	3.35e-06	268	154	9	33640491
Pubmed	Interaction network of human early embryonic transcription factors.	ZNF609 ZBTB9 RFX7 DMAP1 RING1 BCL11B EHMT2 DNAAF10 MED12 PRRC2B	4.09e-06	351	154	10	38297188
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	FLNA FLNB MIA3 SYNM EHBP1L1 EHMT2 TKT MACF1 TNKS1BP1 EXOC1	5.12e-06	360	154	10	33111431
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	TPT1 GALC IMPA2 NPEPPS LAMA3 EML2 MAST2 EHD4 DMKN TKT DGCR8 BRSK1 CPLANE1 PRRC2B	5.18e-06	732	154	14	34732716
Pubmed	UBE2O and USP7 co-regulate RECQL4 ubiquitinylation and homologous recombination-mediated DNA repair.	CCDC8 KLF1 MEPCE MACF1 DGCR8 HCFC1 ZNF646	6.26e-06	155	154	7	34921745
Pubmed	Filamin-interacting proteins, Cfm1 and Cfm2, are essential for the formation of cartilaginous skeletal elements.	FLNA FLNB ACAN	9.99e-06	10	154	3	24436304
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	ZNF219 ZBTB9 POU5F1 PHC1 DMAP1 HCFC1 MED12	1.02e-05	167	154	7	20362541
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	FLNA FLNB MINK1 MAST2 ZNF335 MACF1 PPIP5K1 CGNL1	1.05e-05	234	154	8	36243803
Pubmed	The QTL within the H2 Complex Involved in the Control of Tuberculosis Infection in Mice Is the Classical Class II H2-Ab1 Gene.	ZBTB22 RXRB RING1 RGL2	1.06e-05	31	154	4	26618355
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	UNC13B CUL3 FLNA FLNB ADAMTS1 NPEPPS AHCYL2 ATG2A UBXN1 FEM1C KCTD3 MEPCE HECTD1 HCFC1 GPRASP2 PRRC2B	1.08e-05	1005	154	16	19615732
Pubmed	A human MAP kinase interactome.	FLNA LAMA3 SYNPO FAM13B MACF1 ANKRD24 CGNL1 USF2 CPLANE1 RGL2 WNK2	1.19e-05	486	154	11	20936779
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	CUL3 COL5A2 GAPVD1 SYNPO ZNF318 MAST2 PHC1 PPP1R26 EHBP1L1 ZNF335 PRRC2B SEZ6 ZNF646	1.32e-05	689	154	13	36543142
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TBC1D9B SYNM RNF213 CUL7 PPP1R26 PIKFYVE MACF1 ANKRD24 CGNL1 HECTD1 MED12	1.35e-05	493	154	11	15368895
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	CUL3 FLNA MIA3 MCC NASP CUL7 MACF1 EXOC1 HECTD1	1.46e-05	322	154	9	26514267
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ZHX3 ERCC6 HIRIP3 ZBTB9 NASP SYNPO PHC1 DMAP1 RING1 EHMT2 CDK11B HCFC1	1.84e-05	608	154	12	36089195
Pubmed	Distribution of postsynaptic GABA(A) receptor aggregates in the deep cerebellar nuclei of normal and mutant mice.	GRID2 AGTPBP1	1.95e-05	2	154	2	11984816
Pubmed	Activation of RNA polymerase I transcription by cockayne syndrome group B protein and histone methyltransferase G9a.	ERCC6 EHMT2	1.95e-05	2	154	2	17707230
Pubmed	Disruption of the Flnb gene in mice phenocopies the human disease spondylocarpotarsal synostosis syndrome.	FLNA FLNB	1.95e-05	2	154	2	17635842
Pubmed	Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome.	ADAMTS1 ACAN	1.95e-05	2	154	2	28417352
Pubmed	Combination of germline variations associated with survival of folinic acid, fluorouracil and irinotecan-treated metastatic colorectal cancer patients.	ABCC1 CES1	1.95e-05	2	154	2	31698983
Pubmed	Mutant Cockayne syndrome group B protein inhibits repair of DNA topoisomerase I-DNA covalent complex.	ERCC6 PGBD3	1.95e-05	2	154	2	21143350
Pubmed	Positive Oct -3/4 and D2-40 Immunohistochemical Expression in Germ Cells and Suspected Histology Pattern of Intratubular Germ Cell Neoplasia in Boys with Cryptorchidism Vanish after the Age of 2 Years.	POU5F1 PDPN	1.95e-05	2	154	2	27606906
Pubmed	Filamin depletion blocks endoplasmic spreading and destabilizes force-bearing adhesions.	FLNA FLNB	1.95e-05	2	154	2	21325628
Pubmed	An abundant evolutionarily conserved CSB-PiggyBac fusion protein expressed in Cockayne syndrome.	ERCC6 PGBD3	1.95e-05	2	154	2	18369450
Pubmed	EMG analysis of harmaline-induced tremor in normal and three strains of mutant mice with Purkinje cell degeneration and the role of the inferior olive.	GRID2 AGTPBP1	1.95e-05	2	154	2	7666163
Pubmed	Bral2 is indispensable for the proper localization of brevican and the structural integrity of the perineuronal net in the brainstem and cerebellum.	HAPLN4 BCAN	1.95e-05	2	154	2	22121037
Pubmed	The conserved Cockayne syndrome B-piggyBac fusion protein (CSB-PGBD3) affects DNA repair and induces both interferon-like and innate antiviral responses in CSB-null cells.	ERCC6 PGBD3	1.95e-05	2	154	2	22483866
Pubmed	Structural and functional aspects of filamins.	FLNA FLNB	1.95e-05	2	154	2	11336782
Pubmed	The variants at FLNA and FLNB contribute to the susceptibility of hypertension and stroke with differentially expressed mRNA.	FLNA FLNB	1.95e-05	2	154	2	33649519
Pubmed	Abnormalities in the cerebellar levels of trophic factors BDNF and GDNF in pcd and lurcher cerebellar mutant mice.	GRID2 AGTPBP1	1.95e-05	2	154	2	32109557
Pubmed	What role (if any) does the highly conserved CSB-PGBD3 fusion protein play in Cockayne syndrome?	ERCC6 PGBD3	1.95e-05	2	154	2	23369858
Pubmed	Mutation-related differences in exploratory, spatial, and depressive-like behavior in pcd and Lurcher cerebellar mutant mice.	GRID2 AGTPBP1	1.95e-05	2	154	2	26029065
Pubmed	Gene content of the 750-kb critical region for mouse embryonic ectoderm lethal tcl-w5.	ZBTB22 RXRB RING1 RGL2	1.95e-05	36	154	4	15112104
Pubmed	Deterministic and stochastic allele specific gene expression in single mouse blastomeres.	ANKRD35 POU5F1 HDAC7 RXRB PHC1 KLF1 EHMT2 MIXL1 LRP4 DGCR8	2.11e-05	424	154	10	21731673
Pubmed	Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.	FLNA ANK2 MAST2 MACF1	2.18e-05	37	154	4	27565344
Pubmed	Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.	CCDC8 HIRIP3 NPEPPS MCC AHCYL2 CUL7 RING1 MEPCE CDK11B HECTD1	2.47e-05	432	154	10	23455922
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	CUL3 FLNA FLNB GAPVD1 HIRIP3 OGFR NPEPPS NASP UBXN1 EHD4 EHBP1L1 DNAAF10 ASMTL MEPCE MACF1 TNKS1BP1 HECTD1 HCFC1 TNS3	2.53e-05	1455	154	19	22863883
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	UNC13B CUL3 ANKRD35 MAST2 HMCN2 MACF1 CPLANE1 PRRC2B TNS3	3.58e-05	361	154	9	26167880
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	GAPVD1 MIA3 AFAP1 MACF1 TNKS1BP1 HECTD1 TNS3	4.31e-05	209	154	7	36779422
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	CCDC8 GAPVD1 HIRIP3 SYNM MINK1 RNF213 ZNF318 EFNB1 SUGP2 EHMT2 DGCR8 CGNL1 PRRC2B	4.56e-05	777	154	13	35844135
Pubmed	Filamin A- and formin 2-dependent endocytosis regulates proliferation via the canonical Wnt pathway.	FLNA FLNB BCL11B	4.57e-05	16	154	3	27789627
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	ZNF609 ZNF219 PHC1 DMAP1 EHMT2 HCFC1	4.98e-05	146	154	6	23892456
Pubmed	Ring1B and Suv39h1 delineate distinct chromatin states at bivalent genes during early mouse lineage commitment.	POU5F1 EHMT2 MIXL1	5.53e-05	17	154	3	20573702
Pubmed	A census of human transcription factors: function, expression and evolution.	ZHX3 ZNF444 TBX4 GBX1 POU5F1 RFX7 ZNF236 RXRB BCL11B KLF1 MIXL1 ZNF335 SETBP1 USF2	5.57e-05	908	154	14	19274049
Pubmed	Characterization of 'non-N-methyl-D-Aspartate' binding sites for gacyclidine enantiomers in the rat cerebellar and telencephalic structures.	GRID2 AGTPBP1	5.83e-05	3	154	2	11279275
Pubmed	Interplay between the Chd4/NuRD Complex and the Transcription Factor Znf219 Controls Cardiac Cell Identity.	ZNF219 CORIN	5.83e-05	3	154	2	36076959
Pubmed	Tethering of the conserved piggyBac transposase fusion protein CSB-PGBD3 to chromosomal AP-1 proteins regulates expression of nearby genes in humans.	ERCC6 PGBD3	5.83e-05	3	154	2	23028371
Pubmed	Opposing FlnA and FlnB interactions regulate RhoA activation in guiding dynamic actin stress fiber formation and cell spreading.	FLNA FLNB	5.83e-05	3	154	2	28175289
Pubmed	A rare cause of syndromic short stature: 3M syndrome in three families.	CCDC8 CUL7	5.83e-05	3	154	2	33258289
Pubmed	Physical and functional convergence of the autism risk genes Scn2a and Ank2 in neocortical pyramidal cell dendrites.	ANK2 SCN2A	5.83e-05	3	154	2	38290518
Pubmed	Three M Syndrome	CCDC8 CUL7	5.83e-05	3	154	2	20301654
Pubmed	Filamin A and Filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact.	FLNA FLNB	5.83e-05	3	154	2	12393796
Pubmed	Target neuron controls the integrity of afferent axon phenotype: a study on the Purkinje cell-climbing fiber system in cerebellar mutant mice.	GRID2 AGTPBP1	5.83e-05	3	154	2	7891151
Pubmed	Genomic structure and fine mapping of the two human filamin gene paralogues FLNB and FLNC and comparative analysis of the filamin gene family.	FLNA FLNB	5.83e-05	3	154	2	11153914
Pubmed	Course and targets of the calbindin D-28k subpopulation of primary vestibular afferents.	GRID2 AGTPBP1	5.83e-05	3	154	2	9831049
Pubmed	Filamins as integrators of cell mechanics and signalling.	FLNA FLNB	5.83e-05	3	154	2	11252955
Pubmed	Novel genes in cell cycle control and lipid metabolism with dynamically regulated binding sites for sterol regulatory element-binding protein 1 and RNA polymerase II in HepG2 cells detected by chromatin immunoprecipitation with microarray detection.	FLNA HCFC1	5.83e-05	3	154	2	19292868
Pubmed	G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis.	POU5F1 EHMT2	5.83e-05	3	154	2	16415856
Pubmed	Identification of a conserved cluster of skin-specific genes encoding secreted proteins.	DMKN KRTDAP	5.83e-05	3	154	2	15256262
Pubmed	The genetics of 3-M syndrome: unravelling a potential new regulatory growth pathway.	CCDC8 CUL7	5.83e-05	3	154	2	22156540
Pubmed	GPIbα regulates platelet size by controlling the subcellular localization of filamin.	FLNA FLNB	5.83e-05	3	154	2	22174152
Pubmed	Exome sequencing identifies CCDC8 mutations in 3-M syndrome, suggesting that CCDC8 contributes in a pathway with CUL7 and OBSL1 to control human growth.	CCDC8 CUL7	5.83e-05	3	154	2	21737058
Pubmed	Vestibular ganglion neurons survive the loss of their cerebellar targets.	GRID2 AGTPBP1	5.83e-05	3	154	2	9926858
Pubmed	Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling.	CCDC8 CUL7	5.83e-05	3	154	2	23018678
Pubmed	Sustained generation of neurons destined for neocortex with oxidative metabolic upregulation upon filamin abrogation.	FLNA FLNB	5.83e-05	3	154	2	38989458
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZHX3 ZNF609 ZNF219 TBX4 ZBTB22 POU5F1 ZNF318 ZNF236 RXRB PHC1 ZFP64 USF2 ZNF646	6.77e-05	808	154	13	20412781
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ZHX3 FLNA GAPVD1 ANK2 NASP ZNF318 SUGP2 TKT MEPCE MACF1 TNKS1BP1 CGNL1 HCFC1 PRRC2B	7.51e-05	934	154	14	33916271
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	FLNA FLNB ERCC6 HIRIP3 NASP DMAP1 EHMT2 TNKS1BP1 CDK11B HCFC1	8.79e-05	503	154	10	16964243
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ZNF609 SYNM SUGP2 PPIP5K1 ZNF646	1.03e-04	104	154	5	9205841
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	WHRN ERCC6 SYNPO DNAAF2 BCL11B ACAN SETBP1 HECTD1 HCFC1 AGTPBP1	1.03e-04	513	154	10	25798074
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	ZBTB9 ZNF318 UBXN1 RING1 MEPCE MED12 PRRC2B	1.08e-04	242	154	7	34011540
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ABCC1 GAPVD1 ZNF609 MIA3 MCC RNF213 PIKFYVE CDK11B HECTD1 HCFC1 AGTPBP1 TNS3	1.10e-04	733	154	12	34672954
Pubmed	GABAA/benzodiazepine receptor gamma 2 subunit gene expression in developing normal and mutant mouse cerebellum.	GRID2 AGTPBP1	1.16e-04	4	154	2	8395631
Pubmed	Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines.	ABCC1 POU5F1	1.16e-04	4	154	2	19969351
Pubmed	N-Acetylglucosaminyl transferase regulates the expression of the sulfoglucuronyl glycolipids in specific cell types in cerebellum during development.	GRID2 AGTPBP1	1.16e-04	4	154	2	8910533
Pubmed	Translationally controlled tumor protein (TCTP) downregulates Oct4 expression in mouse pluripotent cells.	TPT1 POU5F1	1.16e-04	4	154	2	22281008
Pubmed	The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin.	FLNA FLNB	1.16e-04	4	154	2	11739414
Pubmed	Interaction of presenilins with the filamin family of actin-binding proteins.	FLNA FLNB	1.16e-04	4	154	2	9437013
Pubmed	Structural interaction and functional regulation of polycystin-2 by filamin.	FLNA FLNB	1.16e-04	4	154	2	22802962
Pubmed	Monoubiquitination of filamin B regulates vascular endothelial growth factor-mediated trafficking of histone deacetylase 7.	FLNB HDAC7	1.16e-04	4	154	2	23401860
Pubmed	Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors.	POU5F1 PDPN	1.16e-04	4	154	2	19483629
Pubmed	The 3M complex maintains microtubule and genome integrity.	CCDC8 CUL7	1.16e-04	4	154	2	24793695
Interaction	FBLN5 interactions	ZNF627 ZNF444 CCDC8 ZBTB9 CUL7 ZXDB DGCR8 GDF11 PRRC2B SENP5	3.61e-07	159	152	10	int:FBLN5
Interaction	HDAC1 interactions	CUL3 ZHX3 FLNA FLNB GAPVD1 ZNF609 ZNF219 ERCC6 ZBTB9 POU5F1 ZNF318 HDAC7 DMAP1 RING1 BCL11B KLF1 EHMT2 ZFP64 TNKS1BP1 HECTD1 HCFC1 MED12 GPRASP2 PGBD3	2.89e-06	1108	152	24	int:HDAC1
Interaction	TERF2IP interactions	CUL3 ZHX3 ZNF444 ZNF609 NUDT14 OGFR NASP ZNF318 PHC1 DMAP1 SUGP2 DNAAF10 MEPCE DGCR8 HECTD1 HCFC1	4.46e-06	552	152	16	int:TERF2IP
Cytoband	Ensembl 112 genes in cytogenetic band chr6p21	ZBTB22 ZBTB9 POU5F1 ZNF318 CUL7 RXRB RING1 EHMT2 RGL2 TNXB	8.57e-06	503	154	10	chr6p21
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZHX3 ZNF627 ZNF444 ZNF609 ZNF219 ZNF628 ZBTB22 ZBTB9 ZBTB47 ZNF318 ZNF236 ZXDB BCL11B KLF1 ZNF335 ZFP64 ZNF646	2.55e-06	718	114	17	28
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	BCAN ACAN	2.35e-04	4	114	2	574
GeneFamily	Cullins	CUL3 CUL7	1.08e-03	8	114	2	1032
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	UNC13B RAD51D WHRN SLC43A2 ZNF609 ERCC6 HIRIP3 KIF1A PLEKHG4 NPEPPS NASP GRID2 AHCYL2 PPP1R26 PDPN BCL11B KLF1 SETBP1 MACF1 PPIP5K1 CDK11B USF2 GDF11 WNK2	1.44e-07	986	152	24	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500	UNC13B RAD51D SLC43A2 HIRIP3 KIF1A PLEKHG4 NASP AHCYL2 PDPN KLF1 SETBP1 PPIP5K1 CDK11B USF2 GDF11 WNK2	5.72e-07	496	152	16	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500
CoexpressionAtlas	ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_2500_k-means-cluster#5	ANKRD35 IMPA2 KIF1A FSTL4 HAPLN4 MUC19 IGSF5 NASP GRID2 BCAN POU5F1 PHC1 HMCN2 TKT ANKRD24 GJC3 CGNL1 LRRC75A SEZ6	7.42e-05	978	152	19	ratio_SC_vs_EB_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000	ABCC1 KIF1A PLEKHG4 SYNM ZBTB47 NASP GRID2 SYNPO APOBR BCL11B HMCN2 KLF1 LRP4 MACF1 CDK11B RAB11FIP4 CGNL1 USF2 SEZ6	7.52e-05	979	152	19	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000
CoexpressionAtlas	MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05	WHRN ATP8B3 ABCC1 AMT TBC1D9B ZNF219 PRR5L NUDT14 ANK2 SYNM AHCYL2 RFX7 PHC1 DMAP1 RING1 EHMT2 LRP4 GDF11 MED12 GPRASP2 WNK2 AGTPBP1	7.87e-05	1245	152	22	PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	COL5A2 FLNA TBX4 AFAP1 SUGP2 LRP4 MACF1 TNS3	3.23e-07	189	154	8	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	COVID-19_Severe-CD8+_Tem\|COVID-19_Severe / Disease condition and Cell class	FLNA PRR5L SPN SYNM CES1 RNF213 ATG2A MACF1	4.10e-07	195	154	8	ff7ae62393e1c858a10592db8e6d9f36b8bae396
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	ANKRD35 CCDC8 ZBTB47 SYNPO CLIC6 PDPN ARHGAP22 EHBP1L1	4.10e-07	195	154	8	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL5A2 TBX4 ANK2 PLEKHG4 PDPN DMKN CGNL1 TNXB	4.96e-07	200	154	8	747c61d4e0b746278ae1f45ca4cd556c6961c76a
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL5A2 TBX4 ANK2 PLEKHG4 PDPN DMKN CGNL1 TNXB	4.96e-07	200	154	8	de1d193f773f4e2927baa6fc38d29754b015c6e6
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	COL5A2 ANK2 ADAMTS1 SYNPO PDPN TNXB GPRASP2	2.83e-06	177	154	7	3d955ea938a1d2fb1b6d68d4997fd454bd632dfc
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	WHRN ZHX3 ZNF219 PRR5L CUL7 ZXDB EHMT2	2.83e-06	177	154	7	eb0cfe8e9a91910f9979608ed47add48d98ce4dd
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ZHX3 ZNF219 ZBTB47 SYNPO CUL7 ZXDB EHMT2	2.93e-06	178	154	7	9d575902d3dbe33437c9d4200df093a741269803
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL5A2 ODAD1 LAMA3 SYNPO SETBP1 TNKS1BP1 CGNL1	3.92e-06	186	154	7	c116cc9f41971622264434ebe29d18e719b0ae19
ToppCell	(04)_Pre-ciliated-(3)_72hpi\|(04)_Pre-ciliated / shred by cell type and Timepoint	GALC EML2 EHBP1L1 DMKN DNAAF10 CRACDL HYDIN	4.21e-06	188	154	7	f911dc61b008b60aaa2a1e9354085f480a669e2c
ToppCell	Macrophages-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	SLC43A2 FLNA SPN CES1 MINK1 EHBP1L1 BRSK1	4.36e-06	189	154	7	c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA ADAMTS1 SYNM GBX1 GRID2 ACAN WNK2	4.83e-06	192	154	7	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA ADAMTS1 SYNM GBX1 GRID2 ACAN WNK2	4.83e-06	192	154	7	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	FLNA PRR5L SPN SYNM RNF213 BCL11B MACF1	5.53e-06	196	154	7	af00c31612e4fe068e5fccae05368edba46bbd20
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 TBX4 ANK2 ADAMTS1 SETBP1 MACF1 TNXB	5.72e-06	197	154	7	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ANKRD35 ANK2 KIF1A PCDHA12 GARIN4 SCN2A LRP4	5.91e-06	198	154	7	d6812494874be0c14361ac2ac3e418b335bb8f55
ToppCell	wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	UNC13B ZNF219 LAMA3 CLIC6 PDPN DMKN TKT	6.11e-06	199	154	7	debdd7dba774d9ccff7effc3f4c132393d203dfa
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL5A2 ANK2 ADAMTS1 PDPN AFAP1 MACF1 TNXB	6.11e-06	199	154	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL5A2 ANK2 ADAMTS1 PDPN AFAP1 MACF1 TNXB	6.11e-06	199	154	7	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184-L1-3\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ADAMTS1 MCC LAMA3 AFAP1 LRP4 TNS3 SEZ6	6.31e-06	200	154	7	140aff451cd58e1d544ee668e49e37e577f6f068
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ADAMTS1 MCC LAMA3 AFAP1 LRP4 TNS3 SEZ6	6.31e-06	200	154	7	85bfa7f4dd07a4d4a88330e88f5886fd1ecfdeeb
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	BCAN PDPN ACAN LRP4 GJC3 TNS3	6.99e-06	133	154	6	63d2f096ae47d9b587acc6c5fbd346e5e58842b8
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IMPA2 LAMA3 BCAN ACAN CORIN ADGRA3	1.34e-05	149	154	6	1e77f03d2b32f366018fec3462d1b75f6e7febb9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA SYNM ODAD1 GBX1 GRID2 ACAN	1.50e-05	152	154	6	bd1f36b436d8ab7dd8420f595b97d851eab31a38
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA SYNM ODAD1 GBX1 GRID2 ACAN	1.50e-05	152	154	6	ee329249a034a969a16b26a224aa04249d67382d
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	PRR5L SPN CES1 ZBTB47 ZNF236 KCTD3	1.55e-05	153	154	6	433b971c98da321204e065019db4e7825c7587cd
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	FSTL4 SYNPO CLIC6 RGS14 BCL11B CRACDL	2.07e-05	161	154	6	ebcd5066e82b7760b9da6adc02d11258d1309dab
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CCDC8 PRDM8 MIXL1 TNXB HYDIN ADGRA3	2.15e-05	162	154	6	56f1789e69a6cb29956e46aba92b290847327c1f
ToppCell	BAL-Control-cDC_6\|Control / Compartment, Disease Groups and Clusters	AMT HIRIP3 SYNM PRDM8 ZFP64 SEZ6	2.64e-05	168	154	6	65ec473cff748b334c0a66e33bc34a8465fe7631
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UNC13B KIF1A CES1 PELI3 GARIN4 SCN2A	3.21e-05	174	154	6	a62531ebf16b32b249168dca11b870f63a8aa81c
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 ZHX3 TBX4 ADAMTS1 MACF1 TNXB	3.31e-05	175	154	6	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA SYNM GBX1 GRID2 ACAN WNK2	3.31e-05	175	154	6	d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA SYNM GBX1 GRID2 ACAN WNK2	3.31e-05	175	154	6	454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0
ToppCell	facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN KLF1 DMKN KRTDAP LRP4 TNXB	3.42e-05	176	154	6	c0a084f7a8645262d61971f094689e02bf15b113
ToppCell	facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN KLF1 DMKN KRTDAP LRP4 TNXB	3.42e-05	176	154	6	cccf9201f6e2da7524b911a5961d3b227edab222
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	ANK2 ADAMTS1 SYNPO PDPN PRDM8 TNXB	3.42e-05	176	154	6	bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L SPN ADAMTS1 RNF213 MACF1 CPLANE1	3.53e-05	177	154	6	d3e6c768b88b7906f3c7fdd00ba20842212c14b1
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L SPN ADAMTS1 RNF213 MACF1 CPLANE1	3.53e-05	177	154	6	f8f101c772c043636bedd6b2ec81409b1d2599bf
ToppCell	COVID-19_Mild-Lymphoid_T/NK-NK_activated\|COVID-19_Mild / Disease group, lineage and cell class	PRR5L SPN ADAMTS1 RNF213 MACF1 CPLANE1	3.53e-05	177	154	6	6978a22fef40c8b455342373abe7593f5ede0fa4
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	PRR5L SPN ADAMTS1 RNF213 MACF1 CPLANE1	3.53e-05	177	154	6	936ab2b180a052387124f68d0c7f41c0b164e748
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRR5L SPN ADAMTS1 RNF213 MACF1 CPLANE1	3.53e-05	177	154	6	d5aeda113afaa2425874394610344570c9078478
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	GAPVD1 SPN ZBTB47 CUL7 ZXDB EHMT2	3.65e-05	178	154	6	536a601abcc60867949ea06e9aafb6c7b799b56b
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZHX3 FEM1C EFNB1 SUGP2 LRP4 MACF1	3.65e-05	178	154	6	c87945146b2734141f07b39d268e0d8086ee0364
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FSTL4 BCL11B CRACDL BRSK1 SLC24A1 SEZ6	3.76e-05	179	154	6	a3922476f33d2e4137a12dbda21a1703dff79684
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic-T_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B4GALNT1 MINK1 FSTL4 IGSF5 AHCYL2 BCL11B	3.88e-05	180	154	6	5fdd10ffdf49f0e818f865ca095a3882b35c640e
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNB MCC CUL7 PDPN PRDM8 TMEM239	3.88e-05	180	154	6	c4068fe47408cfd899131a85fa4b7e5908926f94
ToppCell	10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-LMPP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ZNF219 PRR5L PHC1 BCL11B PPP1R3F PPIP5K1	4.13e-05	182	154	6	69b5cae6fe3bbb0fc60bd2f71b6cfa6cbb0b00ee
ToppCell	facs-Heart-RV\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB MCC HDAC7 EFNB1 DMKN KRTDAP	4.52e-05	185	154	6	7cf2b0db059605032bfae60cf1b93c4c62608f0c
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	OGFR MUC19 LAMA3 APOBR SCN2A AGTPBP1	4.66e-05	186	154	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	COL5A2 TBX4 ADAMTS1 LRP4 MACF1 TNS3	4.94e-05	188	154	6	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	(2)_Fibroblasts-(20)_Fibro-1\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	COL5A2 ANK2 PDPN PRDM8 HMCN2 TNXB	4.94e-05	188	154	6	409a7b69d02e87084ca955e3fe6c77230dee8861
ToppCell	Healthy_donor-NK_CD56bright\|Healthy_donor / disease group, cell group and cell class (v2)	WHRN TPT1 FLNB ATG2A PRDM8 DMKN	5.09e-05	189	154	6	9eac380a3bb4b685effb52d816e1960972660646
ToppCell	Control-B_intermediate-6\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	FLNA FLNB TBC1D9B RNF213 PIKFYVE AGTPBP1	5.09e-05	189	154	6	11cb9a16f1de8f60af2073ed7ea6d4f41c02f299
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA GBX1 GRID2 EHBP1L1 ACAN WNK2	5.09e-05	189	154	6	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA GBX1 GRID2 EHBP1L1 ACAN WNK2	5.09e-05	189	154	6	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLC43A2 FLNA CES1 EHBP1L1 TKT AGTPBP1	5.09e-05	189	154	6	55aba1ebc012006a5db3ff9c92589cb3d9f7c68a
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TPT1 COL5A2 FLNA GAPVD1 MACF1 CGNL1	5.24e-05	190	154	6	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	COL5A2 TBX4 ADAMTS1 LRP4 MACF1 TNS3	5.40e-05	191	154	6	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A2 FLNA GRID2 ACAN SETBP1 CORIN	5.40e-05	191	154	6	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL5A2 TBX4 ANK2 ADAMTS1 AFAP1 SETBP1	5.55e-05	192	154	6	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL5A2 TBX4 ANK2 ADAMTS1 AFAP1 SETBP1	5.55e-05	192	154	6	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	WHRN SYNM LAMA3 CORIN ADGRA3	5.64e-05	118	154	5	3f0a304ef9c9e5ba047fc09f4372590eed624328
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL5A2 PLEKHG4 PDPN DMKN CGNL1 TNXB	5.88e-05	194	154	6	69362e13158033de44f90f3773db6c0f27de8cb3
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL5A2 TBX4 ANK2 ADAMTS1 GRID2 AFAP1	5.88e-05	194	154	6	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-AT2-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ADAMTS1 SYNM ATG2A ZXDB EFNB1 LRP4	5.88e-05	194	154	6	5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c
ToppCell	(1)_T_CD8_CTL\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	FLNA PRR5L SPN SYNM CES1 RNF213	6.05e-05	195	154	6	f582b854e5a4c52764aad5abe4e28ea77a7445f7
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 ANK2 ADAMTS1 HMCN2 SETBP1 TNXB	6.05e-05	195	154	6	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	FLNA PRR5L SPN ADAMTS1 RNF213 MACF1	6.05e-05	195	154	6	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLNA PRR5L SPN ADAMTS1 RNF213 MACF1	6.23e-05	196	154	6	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNA PRR5L SPN ADAMTS1 RNF213 MACF1	6.23e-05	196	154	6	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FLNA PRR5L SPN ADAMTS1 RNF213 MACF1	6.23e-05	196	154	6	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNA PRR5L SPN ADAMTS1 RNF213 MACF1	6.23e-05	196	154	6	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL5A2 ANK2 ADAMTS1 AFAP1 MACF1 TNXB	6.40e-05	197	154	6	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRR5L SPN RNF213 ATG2A BCL11B MACF1	6.40e-05	197	154	6	2b3a56bb1d40bc1284a5931c4e7b373660de5402
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem\|COVID-19_Severe / Disease group, lineage and cell class	PRR5L SPN RNF213 ATG2A BCL11B MACF1	6.40e-05	197	154	6	f0bac4d5c3160933ac3786cec8dadffb35d711ea
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	FLNA PRR5L SPN RNF213 BCL11B MACF1	6.40e-05	197	154	6	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRR5L SPN RNF213 ATG2A BCL11B MACF1	6.40e-05	197	154	6	f73ece3aca28c0db5db0f12e026d42c6c36b9efb
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L SPN RNF213 ATG2A BCL11B MACF1	6.40e-05	197	154	6	e70e7d97823a762def3970d94a0e897981a6c922
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L SPN RNF213 ATG2A BCL11B MACF1	6.40e-05	197	154	6	bce0135a96910d2bace62a3408a1a6fdac0cf0df
ToppCell	COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	FLNA PRR5L SPN RNF213 BCL11B MACF1	6.40e-05	197	154	6	d4dfb3b561d0783cdbee4e8d27009ad81df695cb
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	FLNA SPN RNF213 SETBP1 MACF1 TNKS1BP1	6.59e-05	198	154	6	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	healthy_donor-Lymphocytic-ILC-NK_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	FLNA PRR5L SPN RNF213 APOBR MACF1	6.59e-05	198	154	6	d7053a898e04478c577381085f615edaad3cdc5b
ToppCell	mild-Lymphocytic-CD8_T_cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TPT1 FLNA PRR5L SPN BCL11B MACF1	6.59e-05	198	154	6	629a1229759f3088cafb36f27a3d19d7249aab3a
ToppCell	healthy_donor-Lymphocytic-ILC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	FLNA PRR5L SPN RNF213 APOBR MACF1	6.59e-05	198	154	6	aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCell	COVID_vent-Lymphocytic-ILC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	FLNA PRR5L SPN ADAMTS1 RNF213 MACF1	6.77e-05	199	154	6	e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL5A2 ANK2 ADAMTS1 AFAP1 MACF1 TNXB	6.77e-05	199	154	6	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Control-NK\|Control / Disease condition and Cell class	FLNA PRR5L SPN RNF213 APOBR MACF1	6.77e-05	199	154	6	f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650
ToppCell	COVID_vent-Lymphocytic-ILC-NK_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	FLNA PRR5L SPN ADAMTS1 RNF213 MACF1	6.77e-05	199	154	6	5f914962e2572b0c6372465b81b7496fa663d93c
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL5A2 ANK2 ADAMTS1 PDPN AFAP1 TNXB	6.77e-05	199	154	6	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL5A2 ANK2 ADAMTS1 AFAP1 MACF1 TNXB	6.96e-05	200	154	6	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-MEC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FLNA CCDC8 SYNM LAMA3 PDPN DMKN	6.96e-05	200	154	6	53160551d558148d1d80ec87b90dd6be7d36e4c7
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLNB RNF213 FAM13B HDAC7 EFNB1 MACF1	6.96e-05	200	154	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-MEC-MEC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FLNA CCDC8 SYNM LAMA3 PDPN DMKN	6.96e-05	200	154	6	af4d922659b6f9d446797f7a3922a211e22f88e4
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_Tem\|COVID-19_Severe / Disease, condition lineage and cell class	PRR5L SPN RNF213 ATG2A BCL11B MACF1	6.96e-05	200	154	6	31859b8db7ea17e48b7b54e92f0d76aeb755e7ca
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL5A2 ANK2 ADAMTS1 AFAP1 MACF1 TNXB	6.96e-05	200	154	6	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL5A2 ANK2 ADAMTS1 AFAP1 MACF1 TNXB	6.96e-05	200	154	6	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ADAMTS1 MCC LAMA3 AFAP1 LRP4 SEZ6	6.96e-05	200	154	6	7e51715525fdb001b7042b2bfcb9de81ecb5e4ee
ToppCell	wk_08-11-Epithelial\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	UNC13B ZNF219 LAMA3 CLIC6 DMKN TKT	6.96e-05	200	154	6	445fc7995ffc440c6256a6aab0bbf33fb0fea028
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 TBX4 ANK2 ADAMTS1 SETBP1 TNXB	6.96e-05	200	154	6	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL5A2 ANK2 ADAMTS1 AFAP1 MACF1 TNXB	6.96e-05	200	154	6	44a68bacdb3d5bf563bd35952176995850933a81
Drug	Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A	RAD51D ZNF609 SYNM OGFR MINK1 NASP EML2 AHCYL2 ATG2A CUL7 BCL11B	9.01e-08	194	154	11	7354_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	COL5A2 HIRIP3 SPN SETBP1 MEPCE DGCR8 SLC24A1 HCFC1 MED12	3.10e-06	175	154	9	6316_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	ABCC1 SPN CUL7 MAST2 ZNF335 MEPCE DGCR8 USF2 HCFC1	6.07e-06	190	154	9	1306_DN
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; HL60; HT_HG-U133A	ZNF609 SPN ADAMTS1 ZNF236 RGS14 KLF1 DGCR8 SLC24A1 SENP5	6.34e-06	191	154	9	2499_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	TBC1D9B ERCC6 OGFR MINK1 EML2 UBXN1 AFAP1 IGHMBP2 HCFC1	6.61e-06	192	154	9	4395_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A_EA	FLNB HIRIP3 ZNF236 SNX19 ZNF335 MEPCE DGCR8 USF2 PRRC2B	6.61e-06	192	154	9	1047_DN
Drug	retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A	WHRN SPN ADAMTS1 AHCYL2 EHBP1L1 DGCR8 USF2 HCFC1 PRRC2B	7.19e-06	194	154	9	1211_DN
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ZNF444 MIA3 KIF1A EML2 ZNF318 AHCYL2 BCL11B DGCR8 MED12	7.49e-06	195	154	9	5460_DN
Drug	Bromperidol [10457-90-6]; Down 200; 9.6uM; HL60; HG-U133A	ABCC1 GALC SPN OGFR ATG2A RFX7 MAST2 MACF1 USF2	7.49e-06	195	154	9	1723_DN
Drug	Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A	ZNF444 ZNF219 ERCC6 SPN OGFR MINK1 MAST2 AFAP1 USF2	7.81e-06	196	154	9	3284_DN
Drug	Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A	ZNF609 MINK1 MAST2 RGS14 SUGP2 IGHMBP2 ZFP64 GDF11 MED12	7.81e-06	196	154	9	3353_DN
Drug	Etofenamate [30544-47-9]; Down 200; 10.8uM; HL60; HT_HG-U133A	AMT ERCC6 SPN ZNF318 FEM1C DNAAF2 EHBP1L1 IGHMBP2 PRRC2B	7.81e-06	196	154	9	2907_DN
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A	B4GALNT1 OGFR HDAC7 RGS14 EHBP1L1 BCL11B DGCR8 USF2 SLC24A1	7.81e-06	196	154	9	3637_DN
Drug	Allantoin [97-59-6]; Up 200; 25.2uM; PC3; HT_HG-U133A	WHRN ZNF609 MINK1 ZNF236 ARHGAP22 EFNB1 ACAN DGCR8 USF2	7.81e-06	196	154	9	5052_UP
Drug	Mometasone furoate [83919-23-7]; Down 200; 7.6uM; HL60; HG-U133A	ABCC1 FLNB SPN AHCYL2 ATG2A ZNF236 MAST2 APOBR HCFC1	8.14e-06	197	154	9	1746_DN
Drug	Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A	COL5A2 SPN EML2 BCAN ACAN IGHMBP2 ZFP64 LRP4 CPLANE1	8.14e-06	197	154	9	6383_DN
Drug	Mafenide hydrochloride [138-37-4]; Up 200; 18uM; MCF7; HT_HG-U133A	ZHX3 ZNF609 SPN MINK1 BCAN ZNF318 CUL7 RGS14 SENP5	8.14e-06	197	154	9	5499_UP
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ZNF219 EML2 SUGP2 ZNF335 DGCR8 USF2 GDF11 HCFC1 MED12	8.47e-06	198	154	9	7177_DN
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	AMT OGFR MINK1 SYNPO HDAC7 SUGP2 ZNF335 USF2 PRRC2B	8.47e-06	198	154	9	2069_DN
Drug	Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; HL60; HG-U133A	CUL3 FLNA ZNF609 MIA3 MAST2 DNAAF2 KCTD3 MACF1 USF2	8.82e-06	199	154	9	1994_UP
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; HL60; HT_HG-U133A	KIF1A UBXN1 MAST2 HDAC7 RGS14 MACF1 DGCR8 USF2 SENP5	8.82e-06	199	154	9	2408_UP
Drug	SB 202190; Up 200; 1uM; PC3; HT_HG-U133A	WHRN ZNF609 ZNF219 SPN AHCYL2 RFX7 EFNB1 MACF1 DGCR8	8.82e-06	199	154	9	7058_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZNF609 HIRIP3 ZNF335 ZFP64 MEPCE DGCR8 USF2 MED12	1.71e-05	165	154	8	6085_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	HIRIP3 ZNF236 ZNF335 ZFP64 MEPCE DGCR8 USF2 SLC24A1	2.61e-05	175	154	8	4072_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	RAD51D ZNF335 ZFP64 MEPCE USF2 HCFC1 MED12 TNS3	2.72e-05	176	154	8	6784_DN
Drug	scriptaid; Down 200; 10uM; PC3; HT_HG-U133A	ZNF444 SYNPO CUL7 HDAC7 ZFP64 MEPCE DGCR8 HCFC1	3.45e-05	182	154	8	6896_DN
Drug	Rifabutin [72559-06-9]; Down 200; 4.8uM; PC3; HT_HG-U133A	RAD51D HIRIP3 EML2 HDAC7 ZFP64 MEPCE USF2 SLC24A1	3.59e-05	183	154	8	4527_DN
Drug	Forskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A	WHRN SPN ADAMTS1 AHCYL2 ATG2A MAST2 BCL11B ZNF335	3.59e-05	183	154	8	7059_UP
Drug	azotochelin	ERCC6 PGBD3	4.55e-05	2	154	2	CID000193592
Drug	Pimozide [2062-78-4]; Up 200; 8.6uM; HL60; HG-U133A	UNC13B SPN AHCYL2 MAST2 HDAC7 ACAN USF2 MED12	5.05e-05	192	154	8	1562_UP
Drug	WY-14643; Down 200; 100uM; PC3; HG-U133A	WHRN COL5A2 SPN ADAMTS1 SUGP2 ACAN DGCR8 USF2	5.05e-05	192	154	8	464_DN
Drug	Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A	TRPM4 ZNF444 AHCYL2 MAST2 SUGP2 DGCR8 SLC24A1 PRRC2B	5.24e-05	193	154	8	5440_DN
Drug	Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA	ZNF444 ZNF609 SPN OGFR MCC EML2 CUL7 EHBP1L1	5.24e-05	193	154	8	948_UP
Drug	Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A	COL5A2 ZNF609 B4GALNT1 EHBP1L1 IGHMBP2 SLC24A1 HCFC1 SENP5	5.43e-05	194	154	8	3861_DN
Drug	(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A	ZNF609 MCC EML2 UBXN1 MAST2 HDAC7 ZNF335 SENP5	5.43e-05	194	154	8	4524_DN
Drug	Rolipram [61413-54-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A	CUL3 FLNB OGFR NASP FAM13B BCL11B IGHMBP2 HCFC1	5.43e-05	194	154	8	5330_DN
Drug	Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A	WHRN AMT ZNF219 MINK1 MAST2 BCL11B ZFP64 HCFC1	5.43e-05	194	154	8	3807_DN
Drug	15d-PGJ2; Up 200; 10uM; PC3; HG-U133A	ABCC1 SPN AHCYL2 SUGP2 IGHMBP2 DGCR8 GDF11 PRRC2B	5.43e-05	194	154	8	446_UP
Drug	Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A	KIF1A OGFR MINK1 SYNPO BCAN LRP4 USF2 SLC24A1	5.43e-05	194	154	8	4492_DN
Drug	Miconazole [22916-47-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ZNF444 GALC OGFR NASP ZNF318 MAST2 BCL11B SUGP2	5.43e-05	194	154	8	4960_DN
Drug	Naloxone hydrochloride [357-08-4]; Down 200; 11uM; HL60; HG-U133A	ABCC1 ZNF609 EML2 SUGP2 IGHMBP2 DGCR8 USF2 PRRC2B	5.63e-05	195	154	8	2006_DN
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	COL5A2 ZNF609 SPN APOBR HDAC7 LRP4 HCFC1 MED12	5.63e-05	195	154	8	2805_UP
Drug	Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A	TRPM4 ZNF609 SPN PCDHA5 EHBP1L1 SUGP2 ACAN SENP5	5.63e-05	195	154	8	7468_UP
Drug	Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; HL60; HG-U133A	TPT1 BCAN AHCYL2 ACAN KCTD3 MEPCE MACF1 USF2	5.63e-05	195	154	8	1431_DN
Drug	GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A	ZNF444 AMT B4GALNT1 MINK1 UBXN1 ZNF236 SUGP2 SLC24A1	5.63e-05	195	154	8	7048_UP
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A	AMT ZNF609 SPN OGFR MAST2 HDAC7 SUGP2 USF2	5.84e-05	196	154	8	1323_UP
Drug	Enoxacin [74011-58-8]; Down 200; 12.4uM; HL60; HG-U133A	UNC13B SPN MCC ATG2A APOBR ACAN USF2 SENP5	5.84e-05	196	154	8	1597_DN
Drug	Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; MCF7; HT_HG-U133A	ZNF444 AMT MIA3 OGFR NASP CUL7 AFAP1 USF2	5.84e-05	196	154	8	3296_DN
Drug	17-AAG; Up 200; 1uM; PC3; HT_HG-U133A	KIF1A SPN SYNPO ZNF236 AFAP1 IGHMBP2 LRP4 SLC24A1	5.84e-05	196	154	8	5919_UP
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A	TRPM4 AMT B4GALNT1 ZNF318 SETBP1 DGCR8 SLC24A1 PRRC2B	5.84e-05	196	154	8	6309_DN
Drug	Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A	ZNF444 AMT SPN OGFR EML2 UBXN1 MAST2 DGCR8	5.84e-05	196	154	8	2888_DN
Drug	Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; PC3; HG-U133A	ABCC1 TBC1D9B SPN ADAMTS1 OGFR MCC HDAC7 USF2	6.05e-05	197	154	8	1909_UP
Drug	Acetaminophen [103-90-2]; Up 200; 26.4uM; PC3; HT_HG-U133A	WHRN ZHX3 PCDHA5 UBXN1 BCL11B ACAN IGHMBP2 SENP5	6.05e-05	197	154	8	6284_UP
Drug	Diethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	TPT1 ZNF219 MINK1 MCC UBXN1 RGS14 IGHMBP2 MED12	6.05e-05	197	154	8	7425_DN
Drug	AC1O3LYN	RAD51D ABCC1 ERCC6 PGBD3	6.25e-05	32	154	4	CID006331933
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	ZNF219 SPN OGFR NASP BCAN EFNB1 SUGP2 USF2	6.27e-05	198	154	8	4448_DN
Drug	Glycopyrrolate [596-51-0]; Down 200; 10uM; MCF7; HT_HG-U133A	ABCC1 TRPM4 ZNF609 OGFR AHCYL2 MAST2 EHBP1L1 HCFC1	6.27e-05	198	154	8	3427_DN
Drug	Tranexamic acid [1197-18-8]; Down 200; 25.4uM; PC3; HT_HG-U133A	SPN OGFR ZNF318 MAST2 HDAC7 RGS14 AFAP1 PRRC2B	6.27e-05	198	154	8	2085_DN
Drug	Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; PC3; HT_HG-U133A	WHRN TRPM4 ZNF609 AFAP1 ZNF335 USF2 HCFC1 PRRC2B	6.27e-05	198	154	8	5829_DN
Drug	Pirenperone [ 75444-65-4]; Down 200; 10.2uM; HL60; HT_HG-U133A	CUL3 ZHX3 ZNF444 ZNF609 ZNF219 ERCC6 CUL7 HDAC7	6.27e-05	198	154	8	2455_DN
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	WHRN ZHX3 MIA3 SPN MAST2 SNX19 MACF1 SLC24A1	6.27e-05	198	154	8	4351_DN
Drug	Ebselen [60940-34-3]; Down 200; 14.6uM; HL60; HT_HG-U133A	ZNF444 ZNF609 ZNF219 EML2 SUGP2 DGCR8 USF2 SLC24A1	6.50e-05	199	154	8	2717_DN
Drug	Amoxapine [14028-44-5]; Up 200; 12.8uM; PC3; HG-U133A	ZHX3 ZNF444 ZNF609 TBC1D9B BCAN ZNF318 PPP1R26 ACAN	6.50e-05	199	154	8	1931_UP
Drug	Betulin [473-98-3]; Down 200; 9uM; MCF7; HT_HG-U133A	ZNF219 SPN SYNM MINK1 EML2 AHCYL2 SUGP2 USF2	6.50e-05	199	154	8	7454_DN
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; MCF7; HT_HG-U133A	TBC1D9B KIF1A SPN EML2 MAST2 EHBP1L1 IGHMBP2 HCFC1	6.50e-05	199	154	8	1703_DN
Drug	Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	WHRN ZNF219 SPN MINK1 EML2 PCDHA5 EHBP1L1 SLC24A1	6.50e-05	199	154	8	2289_DN
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; PC3; HT_HG-U133A	CUL3 HIRIP3 SPN SYNPO ZNF318 HDAC7 SETBP1 USF2	6.50e-05	199	154	8	6361_DN
Drug	Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; HL60; HG-U133A	GALC ERCC6 SPN RFX7 ZNF236 MAST2 USF2 GDF11	6.50e-05	199	154	8	1987_UP
Drug	Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; HL60; HG-U133A	SPN NPEPPS AHCYL2 APOBR MACF1 DGCR8 USF2 HCFC1	6.50e-05	199	154	8	2046_DN
Drug	Diazoxide [364-98-7]; Up 200; 17.4uM; PC3; HT_HG-U133A	RAD51D PRR5L KIF1A HDAC7 PDPN RGS14 BCL11B CPLANE1	6.50e-05	199	154	8	5810_UP
Drug	Mesalamine [89-57-6]; Up 200; 26.2uM; MCF7; HT_HG-U133A	CUL3 ZNF444 GALC MINK1 AFAP1 ACAN SLC24A1 HCFC1	6.50e-05	199	154	8	7241_UP
Drug	Amidopyrine [58-15-1]; Down 200; 17.2uM; HL60; HG-U133A	ZNF609 SPN OGFR ACAN KCTD3 USF2 HCFC1 PRRC2B	6.73e-05	200	154	8	1376_DN
Drug	bromochloroacetonitrile	SYNM BCAN	1.36e-04	3	154	2	CID000055004
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZNF444 HIRIP3 ZNF236 ZFP64 MEPCE DGCR8 TNS3	1.40e-04	166	154	7	2247_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	RAD51D HIRIP3 BCL11B ZFP64 MEPCE DGCR8 USF2	1.68e-04	171	154	7	5441_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	HIRIP3 OGFR CUL7 ZNF335 ZFP64 MEPCE USF2	2.07e-04	177	154	7	3177_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ZNF609 ZNF236 HDAC7 ZFP64 MEPCE SLC24A1 PRRC2B	2.46e-04	182	154	7	5802_DN
Drug	Anisomycin [22862-76-6]; Down 200; 15uM; HL60; HT_HG-U133A	IMPA2 MINK1 ZNF318 APOBR ZFP64 PRRC2B TNS3	2.54e-04	183	154	7	1304_DN
Drug	UNC0642	POU5F1 EHMT2	2.70e-04	4	154	2	ctd:C000621860
Drug	Azacytidine-5 [320-67-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A	CUL3 WHRN MINK1 UBXN1 ZNF236 PDPN USF2	2.71e-04	185	154	7	4128_UP
Drug	Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; HL60; HG-U133A	TPT1 SPN BCAN MAST2 ACAN DGCR8 TNS3	2.71e-04	185	154	7	1567_UP
Drug	Antimycin A [1397-94-0]; Down 200; 7.2uM; HL60; HG-U133A	ABCC1 SPN NPEPPS BCAN ACAN DGCR8 USF2	2.99e-04	188	154	7	1414_DN
Drug	Phenacetin [62-44-2]; Up 200; 22.4uM; MCF7; HT_HG-U133A	CUL3 WHRN MCC EHBP1L1 SUGP2 ACAN IGHMBP2	3.09e-04	189	154	7	2832_UP
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A	ZNF444 SPN OGFR CUL7 ARHGAP22 DGCR8 SLC24A1	3.09e-04	189	154	7	3733_DN
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	SPN OGFR MINK1 LRP4 USF2 HCFC1 SENP5	3.19e-04	190	154	7	4340_DN
Drug	Diflunisal [22494-42-4]; Down 200; 16uM; HL60; HG-U133A	SPN BCAN MAST2 ACAN MACF1 USF2 HCFC1	3.19e-04	190	154	7	1990_DN
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZHX3 OGFR MINK1 LAMA3 ZNF318 DNAAF2 DGCR8	3.29e-04	191	154	7	5210_DN
Drug	Carcinine [56897-53-1]; Down 200; 22uM; MCF7; HT_HG-U133A	TRPM4 ZNF219 KIF1A SPN EML2 MAST2 SUGP2	3.51e-04	193	154	7	3242_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A	OGFR MINK1 EML2 HDAC7 RGS14 AFAP1 SLC24A1	3.51e-04	193	154	7	4406_DN
Drug	carbamazepine; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	RAD51D TBC1D9B OGFR MINK1 MAST2 SNX19 EHBP1L1	3.51e-04	193	154	7	835_DN
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A	RAD51D WHRN TBC1D9B OGFR HDAC7 EHBP1L1 SETBP1	3.51e-04	193	154	7	6646_DN
Drug	Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	RAD51D ZNF609 HIRIP3 ZNF318 AHCYL2 HCFC1 MED12	3.62e-04	194	154	7	7406_DN
Drug	Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A	ZHX3 ZNF609 MIA3 MINK1 CUL7 SLC24A1 GDF11	3.62e-04	194	154	7	5268_DN
Drug	Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	WHRN ZHX3 ZNF609 ZFP64 DGCR8 HCFC1 SENP5	3.62e-04	194	154	7	4174_DN
Drug	STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A	SPN OGFR EML2 AFAP1 ACAN DGCR8 HCFC1	3.62e-04	194	154	7	6380_DN
Drug	Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	CUL3 MIA3 ERCC6 SPN OGFR AFAP1 USF2	3.62e-04	194	154	7	3316_DN
Drug	Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A	WHRN ZNF219 OGFR RGS14 SETBP1 CPLANE1 HCFC1	3.62e-04	194	154	7	6656_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	GALC ZNF236 MAST2 KLF1 IGHMBP2 DGCR8 USF2	3.62e-04	194	154	7	2474_DN
Drug	Megestrol acetate [595-33-5]; Down 200; 10.4uM; PC3; HT_HG-U133A	WHRN ZNF609 ZNF219 MINK1 SYNPO AHCYL2 SETBP1	3.62e-04	194	154	7	6667_DN
Drug	Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A	ZNF444 SPN OGFR MINK1 ZNF318 FEM1C MAST2	3.62e-04	194	154	7	3460_DN
Disease	Malignant neoplasm of breast	ABCC1 FLNA FLNB TBC1D9B ERCC6 ANK2 ADAMTS1 HAPLN4 ZNF318 FEM1C HDAC7 RXRB ZFP64 SETBP1 MACF1 MED12 PGBD3 ZNF646	1.13e-05	1074	152	18	C0006142
Disease	Miller-McKusick-Malvaux-Syndrome (3M Syndrome)	CCDC8 CUL7	2.64e-05	2	152	2	C1848862
Disease	Three M Syndrome 1	CCDC8 CUL7	2.64e-05	2	152	2	C2678312
Disease	FG syndrome (is_implicated_in)	FLNA MED12	7.88e-05	3	152	2	DOID:14711 (is_implicated_in)
Disease	myofibrillar myopathy 5 (implicated_via_orthology)	FLNA FLNB	7.88e-05	3	152	2	DOID:0080096 (implicated_via_orthology)
Disease	distal muscular dystrophy 4 (implicated_via_orthology)	FLNA FLNB	7.88e-05	3	152	2	DOID:0111190 (implicated_via_orthology)
Disease	3-M syndrome	CCDC8 CUL7	7.88e-05	3	152	2	cv:C1848862
Disease	FG SYNDROME 4 (disorder)	FLNA MED12	7.88e-05	3	152	2	C1845546
Disease	FG SYNDROME 2	FLNA MED12	7.88e-05	3	152	2	C1845902
Disease	3-M syndrome (is_implicated_in)	CCDC8 CUL7	7.88e-05	3	152	2	DOID:0060241 (is_implicated_in)
Disease	FG SYNDROME 3	FLNA MED12	7.88e-05	3	152	2	C1845567
Disease	FG syndrome	FLNA MED12	7.88e-05	3	152	2	C0220769
Disease	erythritol measurement	NASP MAST2 TKT	8.64e-05	17	152	3	EFO_0021171
Disease	FG syndrome	FLNA MED12	1.57e-04	4	152	2	cv:C0220769
Disease	Malignant Cystosarcoma Phyllodes	FLNA MED12	2.61e-04	5	152	2	C0600066
Disease	Phyllodes Tumor	FLNA MED12	2.61e-04	5	152	2	C0010701
Disease	Seizure, Febrile, Simple	IMPA2 SCN2A	5.44e-04	7	152	2	C0149886
Disease	Seizure, Febrile, Complex	IMPA2 SCN2A	5.44e-04	7	152	2	C0751057
Disease	Disproportionate short stature	FLNA FLNB CUL7 ACAN	6.84e-04	77	152	4	C0878659
Disease	Primary ciliary dyskinesia	ODAD1 DNAAF2 HYDIN	8.45e-04	36	152	3	cv:C0008780
Disease	Febrile Convulsions	IMPA2 SCN2A	9.27e-04	9	152	2	C0009952
Disease	Ehlers-Danlos syndrome (is_implicated_in)	COL5A2 TNXB	9.27e-04	9	152	2	DOID:13359 (is_implicated_in)
Disease	thalamus volume	GALC RFX7 BCL11B MACF1	9.91e-04	85	152	4	EFO_0006935
Disease	Colorectal Carcinoma	UNC13B ABCC1 ERCC6 ANK2 MCC EML2 GRID2 BCL11B DMKN SETBP1 AGTPBP1	1.07e-03	702	152	11	C0009402
Disease	hypertension	FSTL4 MCC IGSF5 RNF213 ZNF318 PRDM8 TNXB	1.10e-03	307	152	7	EFO_0000537
Disease	alopecia areata (is_marker_for)	HDAC7 EHMT2	1.15e-03	10	152	2	DOID:986 (is_marker_for)
Disease	Neurodevelopmental Disorders	CUL3 ANK2 SCN2A SETBP1	1.38e-03	93	152	4	C1535926
Disease	coagulation factor XA measurement	WHRN ABCC1	1.41e-03	11	152	2	EFO_0020266
Disease	Primary Ciliary Dyskinesia	ODAD1 DNAAF2 HYDIN	1.84e-03	47	152	3	C4551720
Disease	diffuse plaque measurement	PRR5L ANK2 FSTL4 MCC CUL7 PPP1R26 BCL11B EHMT2 MACF1 ADGRA3 AGTPBP1	1.96e-03	758	152	11	EFO_0010699
Disease	allergic disease	PRR5L ZBTB9 FEM1C APOBR HDAC7 RGS14	2.26e-03	258	152	6	MONDO_0005271
Disease	Oral ulcer	CCDC8 FEM1C EHMT2 TNXB	2.32e-03	107	152	4	HP_0000155
Disease	Familial thoracic aortic aneurysm and aortic dissection	COL5A2 FLNA MED12	2.60e-03	53	152	3	C4707243
Disease	Germ Cell Cancer	POU5F1 PHC1	2.65e-03	15	152	2	C0740345
Disease	Embryonal Neoplasm	POU5F1 PHC1	2.65e-03	15	152	2	C0027654
Disease	Neoplasms, Germ Cell and Embryonal	POU5F1 PHC1	2.65e-03	15	152	2	C0027658
Disease	Autosomal recessive primary microcephaly	PHC1 ZNF335	2.65e-03	15	152	2	cv:C3711387
Disease	Germ cell tumor	POU5F1 PHC1	2.65e-03	15	152	2	C0205851
Disease	Neoplasms, Embryonal and Mixed	POU5F1 PHC1	2.65e-03	15	152	2	C0205852
Disease	Cancer, Embryonal	POU5F1 PHC1	2.65e-03	15	152	2	C0751364
Disease	Cancer, Embryonal and Mixed	POU5F1 PHC1	2.65e-03	15	152	2	C0751365
Disease	maximal oxygen uptake measurement, response to exercise	SLC43A2 ADAMTS1	3.02e-03	16	152	2	EFO_0004887, EFO_0007768
Disease	bipolar disorder	WHRN ATP8B3 HDAC7 SNX19 BCL11B KRTDAP CRACDL SCN2A WNK2	3.12e-03	577	152	9	MONDO_0004985
Disease	sex interaction measurement, ulcerative colitis	EHMT2 TNXB	3.41e-03	17	152	2	EFO_0000729, EFO_0008343
Disease	angina pectoris	MIA3 RNF213 PRDM8 EHBP1L1	4.05e-03	125	152	4	EFO_0003913
Disease	parental longevity	GAPVD1 ANK2 ADAMTS1 ZBTB22 POU5F1 FAM13B SETBP1 LRRC75A	4.20e-03	494	152	8	EFO_0007796
Disease	osteochondrodysplasia (is_implicated_in)	FLNA FLNB	4.26e-03	19	152	2	DOID:2256 (is_implicated_in)
Disease	unipolar depression, response to bupropion, mood disorder	CUL3 ZHX3	4.26e-03	19	152	2	EFO_0003761, EFO_0004247, EFO_0006326
Disease	susceptibility to cold sores measurement	GRID2 POU5F1 TNXB	4.63e-03	65	152	3	EFO_0008402
Disease	hearing loss	ZNF318 MAST2 ACAN	5.04e-03	67	152	3	EFO_0004238
Disease	cortical thickness	COL5A2 ZHX3 FLNB B4GALNT1 EML2 ZNF318 MAST2 BCL11B KCTD3 LRP4 MACF1 RAB11FIP4 WNK2	5.11e-03	1113	152	13	EFO_0004840

Protein segments in the cluster

Peptide	Gene	Start	Entry
EGSSPGLTEGNTGLV	LINC01547	26	P58512
NPGSVTIFGESAGGE	CES1	211	P23141
GEVTGVTLTGEGQAD	B4GALNT1	191	Q00973
EIDTPGGVGRAGTAA	DNM1P46	171	Q6ZS02
GQEGPLLGTDSTGNV	ADGRA3	1296	Q8IWK6
PSSDGEGVVENGITT	AFAP1	281	Q8N556
TVTVGDEGADTPVGA	EHMT2	71	Q96KQ7
ESSQVLGVEPGGTVA	ANKRD35	466	Q8N283
SDVTQEGSGPAGIRG	ATP8B3	31	O60423
VGEGTPQSSALTEGD	CDK11B	391	P21127
GVSATGVENPGVEAT	ANKRD24	686	Q8TF21
VGSGGDGQSELPAED	DGCR8	51	Q8WYQ5
EGAEVPQGGEETSGA	CLIC6	91	Q96NY7
IVVPTAGEETSGNSG	AGTPBP1	456	Q9UPW5
PLEGQAEGVETTGSQ	ATG2A	1631	Q2TAZ0
AEGVETTGSQEAPGG	ATG2A	1636	Q2TAZ0
ETAVEGDPSGVSGAT	C18orf25	121	Q96B23
EVTEIVGGPGSGKTQ	RAD51D	101	O75771
EQGSEVTGPTFADGE	RAB11FIP4	111	Q86YS3
QGDVGGTCGVVDDEP	ADAMTS1	191	Q9UHI8
GSGEDESGVPVLVTS	ANK2	2641	Q01484
GDEEGGTINNLPGSL	ERCC6	511	P0DP91
GVPRGESEETGSSEG	BCAN	576	Q96GW7
GGSVNFDGETIEGAP	FEM1C	71	Q96JP0
IADSGQGDVQPGTVT	HCFC1	996	P51610
IQGREGNTDVPGAGS	GJC3	116	Q8NFK1
EREVSDSEAGGGPQG	HIRIP3	366	Q9BW71
ISGTDGEGNNVPSGD	LAMA3	1951	Q16787
ESTGEMPGEEGETAG	SLC24A1	751	O60721
EKSGGETQPEGEGET	SLC24A1	771	O60721
TLEGDPGAEGEEGTT	MEPCE	501	Q7L2J0
TDAQRSGPGGGLVEE	NUDT14	161	O95848
GAAGSGVTTLGDPEV	DNAAF2	406	Q9NVR5
EEGAVTVTVGGSGGD	SPN	311	P16150
AETAEGGQGLETVGS	GARIN4	566	Q8IYT1
RPVTEGVSEQDGGST	HMCN2	4161	Q8NDA2
TEPENVTNGTVGGTA	SLC43A2	51	Q8N370
VTNGTVGGTAEPGHE	SLC43A2	56	Q8N370
LGEGPGSGEEVREGT	LRRC75A	301	Q8NAA5
VEGGGSEPTQRDAGS	ASMTL	241	O95671
SGGLGNVDEEPTSVT	KIAA1109	4181	Q2LD37
SEVPGGQSVGVQGEA	FAM13B	446	Q9NYF5
LEGESVSELGAGPSG	GAPVD1	591	Q14C86
VSELGAGPSGSNGVE	GAPVD1	596	Q14C86
GEGAPEIVTGSRDGT	DNAAF10	126	Q96MX6
GGVSGLTGELEFGEN	GRID2	376	O43424
GPGIASTVKTGEEVG	FLNB	1621	O75369
QGATLGGPEEESTIE	KRTDAP	21	P60985
GGETIVFGPDAGSSV	MUC19	236	Q7Z5P9
TGLPGESAEVTGTIG	MUC19	4241	Q7Z5P9
GTIGPSAEETGATGL	MUC19	4991	Q7Z5P9
GTIGPSAEETGATGL	MUC19	5381	Q7Z5P9
GQVIGPSQESAGEVG	CUL7	86	Q14999
VGGSEVPEIATGTAE	EHBP1L1	801	Q8N3D4
SEVAGAQETEVGGSG	EHBP1L1	836	Q8N3D4
AQETEVGGSGISGPE	EHBP1L1	841	Q8N3D4
TVTGGTEELPEEEGG	MED12	1241	Q93074
GETEGSTPGNALVVD	EHD4	106	Q9H223
EAGEVSPPVGAGVNS	PCDHA5	836	Q9Y5H7
EAGGIVIDTSGGPLD	IMPA2	241	O14732
VGSSRGGENTEGGVE	ODAD1	616	Q96M63
SALTASVEEGGVPGE	CRACDL	316	Q6NV74
VNGGSGDAVPSGNEV	NASP	741	P49321
VEEELATSGGQSPTG	MACF1	5581	Q9UPN3
VSGVEDISGLPSGEV	ACAN	1481	P16112
ETSQPEGEAGVGVES	POU5F1	91	Q01860
PDGLEEGARGSQEGS	PRR5L	346	Q6MZQ0
GQTGKEGTENQGVEP	PIKFYVE	1776	Q9Y2I7
GVGSSPGDQSGDENI	MCC	481	P23508
QDGSPQGEGTVTGEL	HECTD1	1291	Q9ULT8
GTGAEEGAPVTAGVT	GBX1	241	Q14549
APGGQGGTEASVEVL	HYDIN	4976	Q4G0P3
VVDGSGSGNEVIEGP	IGSF5	31	Q9NSI5
TGLGGTAEDPGVIAE	KLF1	246	Q13351
VSGDGTQGEGQTEAP	BCL11B	191	Q9C0K0
GGSVAVATPGGTEER	CPLANE1	1831	Q9H799
LGSGEAGPLQSGEES	DMKN	16	Q6E0U4
TGRDIDTGSIPGVDQ	CGNL1	341	Q0VF96
LELGGPEGDAASGTI	DMAP1	11	Q9NPF5
SGPGLERATAGEVGQ	FLNA	1166	P21333
DGSEVGVGGAQVTGS	CUL3	571	Q13618
SVTDSVLGPNGDVTG	FSTL4	676	Q6MZW2
TVNQEEKSGPGASGG	EFNB1	211	P98172
GTDLAVTSLGPGAEG	GDF11	266	O95390
DVGGTDQEFGVEIGP	COL5A2	1481	P05997
GSEPLVTDGEIQGSD	CORIN	81	Q9Y5Q5
EVLSITDAGGGGSPV	BRSK1	401	Q8TDC3
GEGVSGPVTEHSGEQ	MAST2	966	Q6P0Q8
EGESGSVVVQTAPGQ	HAPLN4	41	Q86UW8
VPSGENQSVTGGDEE	EXOC1	141	Q9NV70
LEGGDVVTGDSGGNL	EML2	261	O95834
AEDLETDGGGPGQVV	HDAC7	406	Q8WUI4
TDGGGPGQVVDDGLE	HDAC7	411	Q8WUI4
TGEDGVEISVPVAGA	AMT	226	P48728
EGTSPGDRLGNAGDV	CCDC8	241	Q9H0W5
EIGGDGQTTDGTEPS	GALC	101	P54803
GNGTQPVLSGTGEET	KCTD3	161	Q9Y597
PQDTVSVIGGVAGGS	NPEPPS	806	P55786
TTTMSGGEGEPGEGE	RING1	166	Q06587
GQGQGADVGPSADEV	KIF1A	946	Q12756
EAGEVSPPVGAGVNS	PCDHA12	841	Q9UN75
ESGDEEGGTINNLPG	PGBD3	41	Q8N328
GDSIPITALVGGEGT	MINK1	966	Q8N4C8
TGTQEVGGQDPGEAV	OGFR	426	Q9NZT2
QDAEENGVTGVSGPG	ABCC1	876	P33527
LGATSTGEGPGEVTI	RGL2	306	O15211
GGEALVSPDGTVTEA	AHCYL2	101	Q96HN2
LTREGQGGPGSVSVD	SYNM	971	O15061
EVGQTDQTDSTGGPA	MIA3	701	Q5JRA6
AQGESDTPGVGLVGD	PLEKHG4	116	Q58EX7
VSGAEDQNGGAVPSG	RFFL	296	Q8WZ73
SGEEGLQGEVGPTDL	SYNPO	41	Q8N3V7
GQPEDDTETTGLEGG	PDPN	26	Q86YL7
GGEETEAQRGEVTGP	PELI3	56	Q8N2H9
ICESEPGTEEGAIGG	GPRASP2	406	Q96D09
DISPQDEQGGGVGTK	PRDM8	186	Q9NQV8
QEAELSPDGIATGGG	PRDM8	296	Q9NQV8
SEVQAEGPTALGTGG	PPP1R26	856	Q5T8A7
ITGVDPGSEAEGSGL	WHRN	306	Q9P202
GDQVVNGAGPELSTG	TNS3	671	Q68CZ2
GSEEVTRDSQGEPGG	ARHGAP22	371	Q7Z5H3
VEQKSDQGVEGPGGT	RXRB	311	P28702
PQESQVVVEGGSGEG	TBC1D9B	1121	Q66K14
SEVPEAGGEGLTTQD	APOBR	671	Q0VD83
EGEDQDASIPSGGRG	RNF213	201	Q63HN8
LLDPVGGDVETAGSG	ZXDB	96	P98169
NGESQSPGESGTIVV	SENP5	171	Q96HI0
DVTQGPGATGGKEDS	ZNF444	116	Q8N0Y2
VEQLPSREGGEESGG	TTC30B	136	Q8N4P2
EPNGVGGGISDSSSQ	MIXL1	186	Q9H2W2
GGIGEAVSSAVVGEP	TKT	566	P29401
SLNGGSPEGVESQDG	IGHMBP2	711	P38935
ARELGVGETSGPETQ	TNKS1BP1	1396	Q9C0C2
VSVGTPSEGEGLGAD	SUGP2	1041	Q8IX01
VGGEESEVTVGGLEP	TNXB	2141	P22105
SLIGGNASAEGPEGE	TPT1	46	P13693
GPEGEGTESTVITGV	TPT1	56	P13693
SEGSTVDIGAPAEGE	SCN2A	1141	Q99250
GASGGKGVDANPVET	ZNF609	6	O15014
TGSQGLETQLGGAEP	ZNF646	1411	O15015
GPEGKGTESTVITGV	nan	61	Q56UQ5
GGQGEETFSQIPDGI	ZNF627	76	Q7L945
IENCGSSPGEESEVG	PRRC2B	1541	Q5JSZ5
TVGKGQAPGIEETDG	SEZ6	26	Q53EL9
TGLTENQSGGPLGVD	PHC1	771	P78364
AEGSGCDGPVVLGTE	PPP1R3F	621	Q6ZSY5
TQGSGVDDPVGEVSI	UNC13B	1411	O14795
TGDGLEGAEPSGQLQ	RFX7	101	Q2KHR2
DGELSSTTGPQGQGE	RGS14	21	O43566
EGGDGPGAEEQTAVA	USF2	36	Q15853
GAEAEEGPGTETETG	SNX19	421	Q92543
GREPTSSEQGGLEGS	UBXN1	61	Q04323
RVEDGAGTAGGTVPA	ZBTB47	166	Q9UFB7
CGGESVVGETEAPGV	nan	306	Q3C1V9
STESPVGGEGSELGE	ZBTB9	191	Q96C00
VEQLLSGEGGEESGG	TTC30A	136	Q86WT1
VPSAVSATGETEGGD	ZNF236	1076	Q9UL36
GSGPEIAGVSGVDDL	TBX4	396	P57082
VGVGEPVSSDSGDEG	WNK2	1836	Q9Y3S1
ETGGNAEKVIPGGVS	SETBP1	481	Q9Y6X0
EPSESGLGVGTSEAV	ZNF335	21	Q9H4Z2
DTGSEDQGPGTGELT	ZHX3	896	Q9H4I2
ETDTIGAGEGPQQAV	TMEM239	51	Q8WW34
GSPQEQGVSVVSEEG	ZNF318	1906	Q5VUA4
EGESFAGSVQIPGGT	ZFP64	6	Q9NTW7
GTGSVAGGIESREDP	UBQLN3	551	Q9H347
EDEELGGSSRVPVGG	ZBTB22	336	O15209
EDTLAPGSGGARQGE	TRPM4	316	Q8TD43
ETPGSGAQELSIEGE	PPIP5K1	1216	Q6PFW1
QEGEEGSGLSRPGEA	ZNF219	701	Q9P2Y4
PGEAGDGEASTGVVQ	ZNF628	906	Q5EBL2
NVEEVVSTGLESPGG	LRP4	501	O75096